Description

6-Bromo-3-Methyl-2-4-Tolylquinoline-4-Carboxylic Acid CAS NO 351000-02-7 is a high-purity, advanced pharmaceutical intermediate characterized by its specific quinoline-based molecular architecture. This compound matters as a critical building block in the synthesis of complex active pharmaceutical ingredients (APIs), enabling the development of targeted therapeutic agents. It is primarily needed by research institutions and manufacturers in the pharmaceutical and agrochemical sectors for developing new drug candidates and specialty chemicals.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel quinoline-based drug candidates, particularly in oncology and anti-infective research.
• Agrochemical Research: Used in the development of new herbicides and pesticides, leveraging its heterocyclic structure for biological activity.
• Material Science: Acts as a monomer or additive in the creation of specialty polymers and organic electronic materials.
• Chemical Synthesis: Employed in organic chemistry laboratories for complex coupling reactions and as a scaffold for generating compound libraries.
• Dye & Pigment Industry: Functions as an intermediate for synthesizing specialized quinoline-derived colorants and fluorescent markers.

Basic Information

Product Name	6-Bromo-3-Methyl-2-4-Tolylquinoline-4-Carboxylic Acid
CAS No.	351000-02-7
Molecular Formula	C19H14BrNO2
Molecular Weight	368.23 g/mol
Synonyms	6-Bromo-3-methyl-2-(p-tolyl)quinoline-4-carboxylic acid; 2-(4-Methylphenyl)-6-bromo-3-methyl-4-quinolinecarboxylic acid; 4-Quinolinecarboxylic acid, 6-bromo-3-methyl-2-(4-methylphenyl)-; 6-Bromo-3-methyl-2-(4-methylphenyl)quinoline-4-carboxylic acid; 6-Bromo-3-methyl-2-(p-methylphenyl)-4-quinolinecarboxylic acid; 6-Bromo-3-methyl-2-(4-tolyl)quinoline-4-carboxylic acid; 6-Bromo-3-methyl-2-(p-tolyl)-4-quinolinecarboxylic acid
EINECS	Contact for details

Quality Control

Our 6-Bromo-3-Methyl-2-4-Tolylquinoline-4-Carboxylic Acid is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical specifications. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliability for your most demanding synthesis workflows.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). The product is light-sensitive and should be handled and stored away from direct light exposure. Keep the container tightly sealed when not in use to protect from moisture and contamination.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Assay (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.